{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:35:34Z","timestamp":1759336534813,"version":"3.41.2"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The rise in injection drug use (IDU) has led to an increase in drug-related infections. Harm reduction is an important strategy for preventing infections among people who inject drugs (PWID). We attempted to evaluate the harm reduction counseling that infectious diseases physicians provide to PWID presenting with infections.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>An electronic survey was distributed to physician members of the Emerging Infections Network to inquire about practices used when caring for patients with IDU-related infections.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 534 ID physicians responded to the survey. Of those, 375 (70%) reported routinely caring for PWID. Most respondents report screening for human immunodeficiency virus (HIV) and viral hepatitis (98%) and discussing the risk of these infections (87%); 63% prescribe immunization against viral hepatitis, and 45% discuss HIV preexposure prophylaxis (PrEP). However, 55% of respondents (n = 205) reported not counseling patients on safer injection strategies. Common reasons for not counseling included limited time and a desire to emphasize antibiotic therapy\/medical issues (62%), lack of training (55%), and believing that it would be better addressed by other services (47%). Among respondents who reported counseling PWID, most recommended abstinence from IDU (72%), handwashing and skin cleansing before injection (62%), and safe disposal of needles\/drug equipment used before admission (54%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Almost all ID physicians report screening PWID for HIV and viral hepatitis and discussing the risks of these infections. Despite frequently encountering PWID, fewer than half of ID physicians provide safer injection advice. Opportunities exist to standardize harm reduction education, emphasizing safer injection practices in conjunction with other strategies to prevent infections (eg, HIV PrEP or hepatitis A virus\/hepatitis B virus vaccination).<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofad402","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T21:59:41Z","timestamp":1690322381000},"source":"Crossref","is-referenced-by-count":3,"title":["Harm Reduction: A Missing Piece to the Holistic Care of Patients Who Inject Drugs"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7025-8638","authenticated-orcid":false,"given":"Nathanial S","family":"Nolan","sequence":"first","affiliation":[{"name":"Division of Infectious Disease, VA St Louis Health Care , St Louis, Missouri , USA"},{"name":"Division of Infectious Disease, Washington University School of Medicine , St Louis, Missouri , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah M","family":"Fracasso Francis","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine , St Louis, Missouri , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura R","family":"Marks","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Washington University School of Medicine , St Louis, Missouri , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E","family":"Beekmann","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Carver College of Medicine , Iowa City, Iowa , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip M","family":"Polgreen","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Carver College of Medicine , Iowa City, Iowa , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen Y","family":"Liang","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Washington University School of Medicine , St Louis, Missouri , USA"},{"name":"Department of Emergency Medicine, Washington University School of Medicine , St Louis Missouri , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J","family":"Durkin","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Washington University School of Medicine , St Louis, Missouri , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,7,25]]},"reference":[{"key":"2023081610580172200_ofad402-B1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/cid\/ciac543","article-title":"Estimated number of people who inject drugs in the United States","volume":"76","author":"Bradley","year":"2023","journal-title":"Clin Infect Dis"},{"author":"Ahmad","key":"2023081610580172200_ofad402-B2"},{"key":"2023081610580172200_ofad402-B3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1515195","article-title":"HIV infection linked to injection use of oxymorphone in Indiana, 2014\u20132015","volume":"375","author":"Peters","year":"2016","journal-title":"N Engl J Med"},{"key":"2023081610580172200_ofad402-B4","first-page":"443","article-title":"Community outbreak of HIV infection linked to injection drug use of oxymorphone\u2013Indiana, 2015","volume":"64","author":"Conrad","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023081610580172200_ofad402-B5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.15585\/mmwr.mm6708a6","article-title":"Notes from the field: HIV infection investigation in a rural area\u2014West Virginia, 2017","volume":"67","author":"Evans","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023081610580172200_ofad402-B6","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/cid\/ciz669","article-title":"Prevalence of hepatitis B virus infection among US adults aged 20\u201359 years with a history of injection drug use: National Health and Nutrition Examination Survey, 2001\u20132016","volume":"70","author":"Shing","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023081610580172200_ofad402-B7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.15585\/mmwr.mm6914a2","article-title":"Vital signs: newly reported acute and chronic hepatitis C cases - United States, 2009\u20132018","volume":"69","author":"Ryerson","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023081610580172200_ofad402-B8","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.15585\/mmwr.mm6743a3","article-title":"Hepatitis A virus outbreaks associated with drug use and homelessness\u2014California, Kentucky, Michigan, and Utah, 2017","volume":"67","author":"Foster","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023081610580172200_ofad402-B9","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","article-title":"Hospitalizations related to opioid abuse\/dependence and associated serious infections increased sharply, 2002\u201312","volume":"35","author":"Ronan","year":"2016","journal-title":"Health Aff"},{"author":"National Harm Reduction Coalition","key":"2023081610580172200_ofad402-B10"},{"key":"2023081610580172200_ofad402-B11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/08897077.2016.1263592","article-title":"Behavioral characteristics and injection practices associated with skin and soft tissue infections among people who inject drugs: a community-based observational study","volume":"38","author":"Dahlman","year":"2017","journal-title":"Subst Abus"},{"key":"2023081610580172200_ofad402-B12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12954-016-0112-3","article-title":"Effects of combination approach on harm reduction programs: the Taiwan experience","volume":"13","author":"Lin","year":"2016","journal-title":"Harm Reduct J"},{"author":"Substance Abuse and Mental Health Services Administration.","key":"2023081610580172200_ofad402-B13"},{"key":"2023081610580172200_ofad402-B14","doi-asserted-by":"crossref","first-page":"ofy132","DOI":"10.1093\/ofid\/ofy132","article-title":"Infectious diseases physicians\u2019 perspectives regarding injection drug use and related infections, United States, 2017","volume":"5","author":"Rapoport","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2023081610580172200_ofad402-B15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/cid\/cit932","article-title":"The Infectious Diseases Society of America Emerging Infections Network: bridging the gap between clinical infectious diseases and public health","volume":"58","author":"Pillai","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2023081610580172200_ofad402-B16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","article-title":"Strategies used by people who inject drugs to avoid stigma in healthcare settings","volume":"198","author":"Biancarelli","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"suppl 5","key":"2023081610580172200_ofad402-B17","doi-asserted-by":"crossref","first-page":"S420","DOI":"10.1093\/infdis\/jiaa337","article-title":"Healthcare access and utilization among persons who inject drugs in Medicaid expansion and nonexpansion states: 22 United States cities, 2018","volume":"222","author":"Lewis","year":"2020","journal-title":"J Infect Dis"},{"year":"2022","author":"Centers for Disease Control and Prevention.","key":"2023081610580172200_ofad402-B18"},{"year":"2020","author":"Health Alert Network.","key":"2023081610580172200_ofad402-B19"},{"key":"2023081610580172200_ofad402-B20","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.15585\/mmwr.mm7139a1","article-title":"Widespread hepatitis A outbreaks associated with person-to-person transmission\u2014United States, 2016\u20132020","volume":"71","author":"Foster","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2023081610580172200_ofad402-B21","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/jvh.13379","article-title":"Hepatitis A virus survival on drug paraphernalia","volume":"27","author":"Medrzycki","year":"2020","journal-title":"J Viral Hepat"},{"issue":"suppl 5","key":"2023081610580172200_ofad402-B22","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.1093\/infdis\/jiaa112","article-title":"Responding to outbreaks of human immunodeficiency virus among persons who inject drugs\u2014United States, 2016\u20132019: perspectives on recent experience and lessons learned","volume":"222","author":"Lyss","year":"2020","journal-title":"J Infect Dis"},{"key":"2023081610580172200_ofad402-B23","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"key":"2023081610580172200_ofad402-B24","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1001\/jama.2019.2591","article-title":"Preexposure prophylaxis for the prevention of HIV infection","volume":"321","author":"Chou","year":"2019","journal-title":"JAMA"},{"key":"2023081610580172200_ofad402-B25","doi-asserted-by":"crossref","first-page":"e2221346","DOI":"10.1001\/jamanetworkopen.2022.21346","article-title":"Prevalence of HIV preexposure prophylaxis prescribing among persons with commercial insurance and likely injection drug use","volume":"5","author":"Streed","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2023081610580172200_ofad402-B26","doi-asserted-by":"crossref","first-page":"ofab541","DOI":"10.1093\/ofid\/ofab541","article-title":"Low knowledge of HIV PrEP within a Midwestern US cohort of persons who inject drugs","volume":"9","author":"Sayood","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2023081610580172200_ofad402-B27","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.2105\/AJPH.2018.304561","article-title":"HIV preexposure prophylaxis as a gateway to primary care","volume":"108","author":"Marcus","year":"2018","journal-title":"Am J Public Health"},{"key":"2023081610580172200_ofad402-B28","article-title":"Screening for co-infections in patients with substance use disorders and severe bacterial infections","volume":"9","author":"Varley","year":"2022","journal-title":"Ther Adv Infect Dis"},{"key":"2023081610580172200_ofad402-B29","doi-asserted-by":"crossref","first-page":"ofab489","DOI":"10.1093\/ofid\/ofab489","article-title":"Value of packaged testing for sexually transmitted infections for persons who inject drugs hospitalized with serious injection-related infections","volume":"8","author":"Marks","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"suppl 5","key":"2023081610580172200_ofad402-B30","doi-asserted-by":"crossref","first-page":"S465","DOI":"10.1093\/infdis\/jiaa056","article-title":"The emerging intersection between injection drug use and early syphilis in nonurban areas of Missouri, 2012\u20132018","volume":"222","author":"Reno","year":"2020","journal-title":"J Infect Dis"},{"key":"2023081610580172200_ofad402-B31","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/cid\/ciz804","article-title":"Infectious complications of addiction: a call for a new subspecialty within infectious diseases","volume":"70","author":"Serota","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023081610580172200_ofad402-B32","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"2023081610580172200_ofad402-B33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2013.07.001","article-title":"Interventions to prevent HIV and hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness","volume":"25","author":"MacArthur","year":"2014","journal-title":"Int J Drug Policy"},{"author":"Substance Abuse and Mental Health Services Administration","key":"2023081610580172200_ofad402-B34"},{"key":"2023081610580172200_ofad402-B35","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/cid\/ciac909","article-title":"Prevalence, distribution, and characteristics associated with possession of buprenorphine waivers among infectious diseases physicians in the United States","volume":"76","author":"Fujita","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2023081610580172200_ofad402-B36","doi-asserted-by":"crossref","first-page":"ofaa503","DOI":"10.1093\/ofid\/ofaa503","article-title":"Opportunities to offer harm reduction to people who inject drugs during infectious disease encounters: narrative review","volume":"7","author":"Peckham","year":"2020","journal-title":"Open Forum Infect Dis"},{"author":"Substance Abuse and Mental Health Services Administration (SAMHSA).","key":"2023081610580172200_ofad402-B37"},{"key":"2023081610580172200_ofad402-B38","doi-asserted-by":"crossref","first-page":"ofac688","DOI":"10.1093\/ofid\/ofac688","article-title":"Integrated infectious disease and substance use disorder care for the treatment of injection drug use\u2013associated infections: a prospective cohort study with historical control","volume":"10","author":"Serota","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2023081610580172200_ofad402-B39","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1186\/s12879-021-06514-9","article-title":"\u201cOPTIONS-DC\u201d, a feasible discharge planning conference to expand infection treatment options for people with substance use disorder","volume":"21","author":"Sikka","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2023081610580172200_ofad402-B40","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/cid\/ciz654","article-title":"Outpatient parenteral antimicrobial therapy plus buprenorphine for opioid use disorder and severe injection-related infections","volume":"70","author":"Fanucchi","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023081610580172200_ofad402-B41","doi-asserted-by":"crossref","first-page":"e237888","DOI":"10.1001\/jamanetworkopen.2023.7888","article-title":"Estimated clinical outcomes and cost-effectiveness associated with provision of addiction treatment in US primary care clinics","volume":"6","author":"Jawa","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2023081610580172200_ofad402-B42","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/cid\/ciaa823","article-title":"Hospital costs of injection drug use in Florida","volume":"72","author":"Coye","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofad402\/50961272\/ofad402.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/8\/ofad402\/51115656\/ofad402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/8\/ofad402\/51115656\/ofad402.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T10:58:24Z","timestamp":1692183504000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofad402\/7231050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofad402","relation":{},"ISSN":["2328-8957"],"issn-type":[{"type":"electronic","value":"2328-8957"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,7,25]]},"article-number":"ofad402"}}